Is Semaglutide legal in United States?

Semaglutide is among the peptides readers most often ask about in United States. This page focuses on the regulatory reality there, not on how to obtain or use it, because that is where reliable, localized information is hardest to find.

In United States, Semaglutide is an authorised, prescription-only medicine, regulated by FDA (U.S. Food and Drug Administration). The FDA approved Ozempic (2017), Rybelsus (2019) and Wegovy (2021), all prescription-only.

Semaglutide is supplied through pharmacies on prescription. Importing prescription medicines outside regulated channels is restricted, and customs may detain shipments. Personal importation of unapproved or foreign versions is generally not permitted. Holding Semaglutide on a valid prescription is lawful in United States; obtaining or holding it without a prescription is not.

A note specific to the US: semaglutide spent a period on the FDA drug-shortage list, during which compounding pharmacies could prepare versions of it. The FDA later declared the shortage resolved and began winding that down, so large-scale compounding of semaglutide “copies” is no longer permitted under 503A/503B enforcement discretion. The branded products remain the authorised, prescription-only route.

Selling or supplying Semaglutide without the required authorisation is an offence in United States. FDA (U.S. Food and Drug Administration) sets out the applicable sanctions; we do not reproduce specific figures here because they change. Confirm the current penalties with the regulator. This page reflects our reading of the position as of the last-verified date; regulations change, so confirm with FDA (U.S. Food and Drug Administration) before making any decision.